Press Releases Juniper Biologics In-Licenses Helsinn’s Oncology Portfolio For Aloxi®, Onicit®, Paloxi®, Akynzeo® and Anamorelin (INN) Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive « Previous 1 2 3 4